Developing an active surveillance protocol for patients receiving a diagnosis of prostate cancer after HoLEP
Ashley E. Ross, MD, PhD, provides an overview of his institution’s new protocol for this subset of patients.
In this video, Ashley E. Ross, MD, PhD, discusses an active surveillance protocol for patients undergoing holmium laser enucleation of the prostate for benign prostatic hyperplasia who subsequently receive a diagnosis of prostate cancer. Ross is an associate professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Study: Lower PCSM is seen with radical prostatectomy vs other modalities
November 14th 2023"This large registry study with data from varied practice settings, incorporating the most commonly used treatment modalities, provides useful data on the long-term mortality outcomes," writes Badar M. Mian, MD.
Comparing Leuprolide Formulations in Advanced Prostate Cancer
November 13th 2023In the third article of the series, Melanie McGilloway, NP-C, an advanced practice provider at Genesis Urology in San Diego, discusses the various formulations of leuprolide, a gonadotropin-releasing hormone (GnRH) agonist used for treating advanced prostate cancer.
